Literature DB >> 30874320

Glutathione transferase Omega 1-1 (GSTO1-1) modulates Akt and MEK1/2 signaling in human neuroblastoma cell SH-SY5Y.

Chonticha Saisawang1, Jantana Wongsantichon2,3, Robert C Robinson2,4, Albert J Ketterman1.   

Abstract

In the human neuroblastoma SH-SY5Y cell line, the glutathione transferase Omega 1-1 (GSTO1-1) appears to modulate Akt and MEK1/2 kinase activation. We observed a glutathionylation modification was involved in the activation of Akt but not MEK1/2. With the specific GSTO1-1 inhibitor ML175, we show the enzyme activity of GSTO1-1 is important for modulation as the inhibited GSTO1-1 allowed activation of both Akt and MEK1/2. The inhibition of GSTO1-1 showed a similar extent of activation of Akt and MEK1/2 as treatment by the endotoxin lipopolysaccharide. The GSTO1-1 also either directly interacts with Akt and MEK1/2 or interacts with a protein complexed with Akt and MEK1/2 as both kinases coimmunoprecipitated with GSTO1-1. The results suggest that GSTO1-1 enzyme activity inhibits the activation of these two kinases to maintain basal levels. The possible regulation by GSTO1-1 is of interest as both kinases have hundreds of potential downstream targets that are known to have contributions to various cellular processes including survival, growth, proliferation, and metabolism.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Akt/PKB; MEK1/2; ML175; glutathione transferase (GST); glutathionylation

Mesh:

Substances:

Year:  2019        PMID: 30874320     DOI: 10.1002/prot.25683

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  2 in total

Review 1.  Glutathione S-Transferases in Cancer.

Authors:  Rahul Raj Singh; Katie M Reindl
Journal:  Antioxidants (Basel)       Date:  2021-04-29

2.  Glutathione S-Transferase Alpha 4 Promotes Proliferation and Chemoresistance in Colorectal Cancer Cells.

Authors:  Zhanhu Zhang; Lili Xu; Lin Huang; Tianqi Li; Jane Y Wang; Chunhua Ma; Xiaoyun Bian; Xiaoyan Ren; Haibo Li; Xingmin Wang
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.